FCMI
Foresite Capital Management IV Portfolio holdings
AUM
$124M
1-Year Return
24.36%
This Quarter Return
-19.06%
1 Year Return
-24.36%
3 Year Return
+1.86%
5 Year Return
+16.17%
10 Year Return
–
AUM
$81.1M
AUM Growth
-$151M
(-65%)
Cap. Flow
-$108M
Cap. Flow
% of AUM
-133.3%
Top 10 Holdings %
Top 10 Hldgs %
98.88%
Holding
18
New
4
Increased
2
Reduced
5
Closed
7
Top Buys
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$5.32M |
| 2 |
BLUE
bluebird bio
BLUE
|
+$2.3M |
| 3 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$2.2M |
| 4 |
Kiniksa Pharmaceuticals
KNSA
|
+$1.01M |
| 5 |
uniQure
QURE
|
+$905K |
Top Sells
| 1 |
MDCO
Medicines Co
MDCO
|
+$34.2M |
| 2 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
+$17.2M |
| 3 |
Insmed
INSM
|
+$12M |
| 4 |
Arbutus Biopharma
ABUS
|
+$10.3M |
| 5 |
Ascendis Pharma
ASND
|
+$9.6M |
Sector Composition
| 1 | Healthcare | 96.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cytokinetics
CYTK
$6.12B
| $25.7M | 31.64% |
2,177,292
-221,678
| -9% | -$2.61M |
|
|
MYOK
2
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $14.4M | 17.76% |
307,400
+47,030
| +18% | +$2.2M |
|
3
Fulcrum Therapeutics
FULC
$379M
| $11.9M | 14.7% |
998,655
-501,345
| -33% | -$5.99M |
|
|
4
Insmed
INSM
$30.8B
| $10.9M | 13.4% |
678,322
-751,196
| -53% | -$12M |
|
|
BHVN
5
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $5.32M | 6.56% |
+156,355
| New | +$5.32M |
|
6
Voyager Therapeutics
VYGR
$232M
| $4.73M | 5.83% |
516,751
-313,814
| -38% | -$2.87M |
|
|
AERI
7
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $3.07M | 3.79% |
227,717
-1,273,683
| -85% | -$17.2M |
|
|
BLUE
8
DELISTED
bluebird bio
BLUE
| $2.3M | 2.83% |
+3,860
| New | +$2.3M |
|
|
9
Kiniksa Pharmaceuticals
KNSA
$2.75B
| $1.01M | 1.24% |
+65,000
| New | +$1.01M |
|
10
Kura Oncology
KURA
$711M
| $925K | 1.14% |
93,000
+25,000
| +37% | +$249K |
|
|
11
uniQure
QURE
$904M
| $905K | 1.12% |
+19,082
| New | +$905K |
|
|
12
Arbutus Biopharma
ABUS
$855M
| – | – |
-3,705,128
| Closed | -$10.3M |
|
13
Alector
ALEC
$278M
| – | – |
-353,462
| Closed | -$6.09M |
|
|
14
Ascendis Pharma
ASND
$11.8B
| – | – |
-68,981
| Closed | -$9.6M |
|
|
OPTN
15
DELISTED
OptiNose
OPTN
| – | – |
-58,051
| Closed | -$8.03M |
|
16
SI-BONE Inc
SIBN
$677M
| – | – |
-308,183
| Closed | -$6.63M |
|
|
CBAY
17
DELISTED
Cymabay Therapeutics
CBAY
| – | – |
-2,315,016
| Closed | -$4.54M |
|
|
MDCO
18
DELISTED
Medicines Co
MDCO
| – | – |
-403,217
| Closed | -$34.2M |
|